Safety of Recombinant Adeno-Associated Virus Type 2–RPE65 Vector Delivered by Ocular Subretinal Injection

This publication has 34 references indexed in Scilit:

• Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood Blindness
  Molecular Therapy, 2005
• AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis
  Molecular Therapy, 2005
• Recent developments in gene transfer: risk and ethics
  BMJ, 2005
• Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives
  Gene Therapy, 2004
• AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice
  Molecular Therapy, 2004
• Changes in intraocular pressure and pupil size following intramuscular administration of hydromorphone hydrochloride and acepromazine in clinically normal dogs
  Veterinary Ophthalmology, 2003
• Practical considerations of recombinant adeno‐associated virus‐mediated gene transfer for treatment of retinal degenerations
  The Journal of Gene Medicine, 2003
• Factors Affecting the Interpretation of Canine and Nonhuman Primate Clinical Pathology
  Toxicologic Pathology, 2003
• Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors
  Gene Therapy, 2001
• Concordance and recessive inheritance of Leber congenital amaurosis
  American Journal of Medical Genetics, 1993